AMATO, MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.445
EU - Europa 15.352
AS - Asia 9.902
SA - Sud America 2.145
OC - Oceania 281
AF - Africa 271
Continente sconosciuto - Info sul continente non disponibili 9
Totale 52.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.224
RU - Federazione Russa 5.370
PL - Polonia 2.883
SG - Singapore 2.850
CN - Cina 2.189
IT - Italia 2.149
HK - Hong Kong 1.860
BR - Brasile 1.761
IE - Irlanda 1.275
KR - Corea 1.197
SE - Svezia 1.070
VN - Vietnam 621
DE - Germania 498
UA - Ucraina 441
FI - Finlandia 411
IN - India 377
BE - Belgio 345
GB - Regno Unito 288
AU - Australia 276
TR - Turchia 177
FR - Francia 175
AR - Argentina 166
NL - Olanda 144
ID - Indonesia 123
CA - Canada 114
JO - Giordania 87
JP - Giappone 82
BD - Bangladesh 80
CI - Costa d'Avorio 74
EC - Ecuador 73
MX - Messico 72
ES - Italia 71
ZA - Sudafrica 60
CH - Svizzera 56
IQ - Iraq 49
AT - Austria 47
CO - Colombia 39
IR - Iran 30
PY - Paraguay 27
CZ - Repubblica Ceca 26
EG - Egitto 26
MA - Marocco 25
SC - Seychelles 25
UZ - Uzbekistan 25
PK - Pakistan 24
CL - Cile 23
VE - Venezuela 23
PE - Perù 19
PH - Filippine 17
MK - Macedonia 15
AE - Emirati Arabi Uniti 14
SA - Arabia Saudita 12
AZ - Azerbaigian 11
KE - Kenya 11
KZ - Kazakistan 11
BG - Bulgaria 9
DZ - Algeria 9
EU - Europa 9
GR - Grecia 9
LT - Lituania 9
PT - Portogallo 9
TN - Tunisia 9
UY - Uruguay 9
BJ - Benin 8
IL - Israele 8
OM - Oman 8
PA - Panama 8
HN - Honduras 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
BH - Bahrain 6
GE - Georgia 6
NP - Nepal 6
AL - Albania 5
ET - Etiopia 5
JM - Giamaica 5
MY - Malesia 5
NO - Norvegia 5
RS - Serbia 5
SN - Senegal 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
CR - Costa Rica 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
CY - Cipro 2
EE - Estonia 2
MD - Moldavia 2
ML - Mali 2
Totale 52.376
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.690
Warsaw 2.865
Fairfield 2.862
Ashburn 2.107
Singapore 1.890
Hong Kong 1.550
Woodbridge 1.352
Dublin 1.264
Seoul 1.186
Cambridge 1.181
Seattle 1.165
Chandler 1.121
Houston 1.057
Wilmington 932
Hefei 680
Jacksonville 664
Altamura 569
Lawrence 542
Beijing 516
Princeton 439
Ann Arbor 403
Buffalo 359
Moscow 309
Los Angeles 295
Melbourne 272
Boston 264
Mumbai 244
Florence 230
Ho Chi Minh City 221
Medford 195
Boardman 186
The Dalles 152
San Diego 143
Kent 139
Munich 136
Asse 132
Reet 132
New York 125
São Paulo 123
Izmir 117
Milan 115
Hanoi 96
Dallas 95
Clifton 92
Shanghai 87
Paris 85
Abidjan 74
Helsinki 71
Jakarta 65
Norwalk 64
Falls Church 56
Dearborn 54
Meise 54
Tokyo 53
Dong Ket 52
Redondo Beach 52
London 50
Barcelona 49
Turku 49
Hillsboro 48
Rio de Janeiro 48
Toronto 47
Rome 46
Andover 42
West Jordan 42
San Jose 40
Yubileyny 40
Bern 39
Bengaluru 36
Chicago 36
Belo Horizonte 35
Brasília 35
Brooklyn 34
Haiphong 30
Bologna 29
Quito 29
Chennai 28
Curitiba 28
Phoenix 28
Turin 27
Verona 27
Campinas 26
Frankfurt am Main 26
Salerno 26
Johannesburg 25
Montreal 25
Tianjin 24
Tashkent 23
Durham 22
Vienna 22
Denver 21
Biên Hòa 20
Brussels 20
Guayaquil 20
Lappeenranta 20
Guangzhou 19
Naples 19
Brno 18
Cape Town 18
Da Nang 18
Totale 35.328
Salva come PNG Salva come JPEG
Nome #
Multiple sclerosis progression: time for a new mechanism-driven framework 570
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 452
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. 423
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 300
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 293
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis. 285
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 285
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients. 283
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 280
EPIDURAL ANALGESIA AND CESAREAN DELIVERY IN MULTIPLE SCLEROSIS POST PARTU RELAPSES: THE ITALIAN COHORT STUDY. 277
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. 277
The Italian multiple sclerosis register. 276
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 274
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. 272
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 266
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene. 258
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 251
Radiologically isolated syndrome: 5-year risk for an initial clinical event. 242
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. 241
Geographical variations in sex ratio trends over time in multiple sclerosis 239
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. 231
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop 228
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 227
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 222
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 220
Anxiety state affects information processing speed in patients with multiple sclerosis. 213
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab 212
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study 205
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 203
Identifying risk factors for cognitive issues in Multiple Sclerosis 201
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. 200
Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population. 199
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study. 196
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 195
Cognitive assessment in multiple sclerosis-an Italian consensus 195
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. 191
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. 188
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 187
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability 185
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 183
Cognitive impairment in multiple sclerosis: a longitudinal study 181
Cognitive impairment in early stages of multiple sclerosis. 181
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 180
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 179
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. 178
Impact of cognitive impairment on coping strategies in multiple sclerosis. 176
Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their Caregivers 176
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 174
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 174
Changes in neuropsychological test performance over the workday in multiple sclerosis. 169
The World Health Organization cross-national research program on age-associated dementias. 169
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 169
The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports 168
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 168
Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach 167
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 167
A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse 166
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 166
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. 165
Quality of life in multiple sclerosis: The impact of depression, fatigue and disability 164
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 164
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients 163
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 162
Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support 161
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 160
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 160
Are there protective treatments for cognitive decline in MS? 158
Multiple Sclerosis Progression and Relapse Activity in Children 155
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 155
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. 155
Association of Neocortical Volume Changes with Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis 155
Emotional and neutral verbal memory impairment in Multiple Sclerosis. 155
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 155
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 154
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. 154
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 154
Cognitive impairment in multiple sclerosis. 153
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 152
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 152
Electronystagmography in the diagnosis of multiple sclerosis. 151
Cognitive and psychosocial features of childhood and juvenile MS. 151
Impatto funzionale 151
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. 150
A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. 150
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 150
Psychosocial issue in children and adolescents with multiple sclerosis. 149
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. 149
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary 148
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. 147
Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions. 147
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 147
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. 147
A prospective study on the prognosis of multiple sclerosis. 144
Cognitive changes in multiple sclerosis 144
Cognitive dysfunction in multiple sclerosis: current approaches to clinical management. 144
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis. 144
Subclinical MS. Follow-up of four cases 142
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals. 142
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 141
New natural history of interferon-b treated relapsing multiple sclerosis 140
Totale 19.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.192 0 0 0 0 0 432 158 314 338 453 220 277
2021/20222.477 85 242 178 96 85 125 103 185 166 107 405 700
2022/20235.896 722 1.351 190 367 425 1.051 710 271 533 34 147 95
2023/20242.308 106 250 429 159 163 183 100 400 54 208 164 92
2024/202514.953 688 1.740 913 2.075 4.035 1.849 251 755 940 449 584 674
2025/202611.392 1.850 2.677 2.171 2.121 2.151 422 0 0 0 0 0 0
Totale 52.936